WASHINGTON—Attorney General Eric Holder confirmed Wednesday that federal authorities were investigating the data breach involving retail giant Target.
“The Department of Justice takes seriously reports of any data breach, particularly those involving personally identifiable or financial information, and looks into allegations that are brought to its attention,” Holder told the Senate Judiciary Committee.
“While we generally do not discuss specific matters under investigation, I can confirm the department is investigating the breach involving the U.S. retailer, Target. And we are committed to working to find not only the perpetrators of these sorts of data breaches – but also any individuals and groups who exploit that data via credit card fraud.”
CYBERTRUTH: How to boost security of your payment cards
Top Tech Companies To Invest In Right Now: Agilysys Inc .(AGYS)
Agilysys, Inc., together with its subsidiaries, provides information technology (IT) solutions to corporate and public-sector customers primarily in North America. It operates in three segments: Hospitality Solutions Group (HSG), Retail Solutions Group (RSG), and Technology Solutions Group (TSG). The HSG segment offers application software and services that streamline management of operations, property, and inventory for customers in the gaming, hotel and resort, cruise lines, food management services, and sports and entertainment markets. The RSG segment provides solutions for retailers to enhance productivity, operational efficiency, technology utilization, customer satisfaction, and in-store profitability that comprise customized pricing, inventory, and customer relationship management systems. This segment also offers implementation plans and supplies the hardware package required to operate the systems, including servers, receipt printers, point-of-sale terminals, and wireless devices for in-store use by retail store associates. The TSG segment provides various solutions that comprise enterprise architecture, infrastructure optimization, storage and resource management, identity management, and business continuity for the finance, government, healthcare, telecommunications, education, and other industries. The company was founded in 1963 and is headquartered in Solon, Ohio.
- [By Evan Niu, CFA]
What: Shares of Agilysys (NASDAQ: AGYS ) have soared today by as much as 11% after the company reported earnings.
So what: Revenue in the fiscal fourth quarter rose 21% to $63 million, with the company’s retail segment driving nearly all of those gains. Non-GAAP net income per share came in at $0.15, swinging into the black relative to the $0.16 per share adjusted loss a year ago. CEO James Dennedy said the company outperformed its expectations for the year.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Agilysys (Nasdaq: AGYS ) , whose recent revenue and earnings are plotted below.
Top Tech Companies To Invest In Right Now: Fluidigm Corporation(FLDM)
Fluidigm Corporation engages in the development, manufacture, and marketing of microfluidic systems for growth markets in the life science and agricultural biotechnology (Ag-Bio) industries. The company?s proprietary microfluidic systems consist of instruments and consumables, including chips (integrated fluidic circuits) and reagents. Its technology enables customers to perform and measure various biochemical reactions on samples smaller than the content of a single cell by utilizing minute volumes of reagents and samples; and rapid preparation of multiple samples in parallel for next generation DNA sequencing. The company?s products include the BioMark HD system, which performs high-throughput gene expression analysis using real-time and end point PCR, SNP genotyping, single-cell analysis, and digital PCR using TaqMan, EvaGreen dye, and other chemistries; The EP1 System that performs end point PCR and is commonly used in production settings for Ag-Bio, digital PCR, and c opy number variation experiments using TaqMan, EvaGreen dye, and other chemistries; and the Access Array system that enables automated sample preparation and tagging for next generation DNA sequencers. The company serves pharmaceutical and biotechnology companies, academic institutions, diagnostic laboratories, and Ag-Bio companies. Fluidigm Corporation distributes its instruments and supplies through direct field sales and support organizations in North America, Europe, and Japan; and through distributors or sales agents in parts of Europe, Latin America, the Middle East, and the Asia-Pacific region. The company was formerly known as Mycometrix Corporation and changed its name to Fluidigm Corporation in April 2001. Fluidigm Corporation was founded in 1999 and is headquartered in South San Francisco, California.
- [By John Kell]
Bio-technology company Fluidigm Corp.(FLDM) agreed to acquire DVS Sciences Inc. for about $208 million to expand its portfolio of single-cell technology products. DVS manufactures and distributes bioanalytical products for biological research and future clinical applications. Shares dropped 2.3% to $40.02 premarket.
- [By Sean Williams]
What: Shares of Fluidigm (NASDAQ: FLDM ) , a manufacturer of microfluidic systems for the biotech, pharmaceutical, and academic research sectors, shot higher by as much as 14% after reporting its first-quarter-earnings results.
- [By Seth Jayson]
Fluidigm (Nasdaq: FLDM ) reported earnings on May 1. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Fluidigm beat slightly on revenues and exceeded expectations on earnings per share.
- [By Seth Jayson]
In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven’t materialized. Is the current inventory situation at Fluidigm (Nasdaq: FLDM ) out of line? To figure that out, start by comparing the company’s inventory growth to sales growth. How is Fluidigm doing by this quick checkup? At first glance, pretty well. Trailing-12-month revenue increased 24.0%, and inventory increased 14.4%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue expanded 32.8%, and inventory increased 14.4%. Over the sequential quarterly period, the trend looks worrisome. Revenue dropped 7.2%, and inventory grew 2.8%.
Top Tech Companies To Invest In Right Now: PC-Tel Inc.(PCTI)
PCTEL, Inc. provides propagation and optimization solutions for the wireless industry. It designs and develops software-based radios (scanning receivers) for wireless network optimization; and develops and distributes antenna solutions. The company?s scanning receivers, receiver-based products, and interference management solutions are used to measure, monitor, and optimize cellular networks. It offers various antenna products for worldwide interoperability for microwave access antennas, land mobile radio antennas, and precision global positioning systems antennas that serve applications in telemetry, radio frequency identification, WiFi, fleet management, and mesh networks. The company?s antenna solutions address public safety, military, and government applications; supervisory control and data acquisition, health care, energy, smart grid, and agricultural applications; and indoor wireless, wireless backhaul, and cellular applications. PCTEL, Inc. supplies its products to public and private carriers, wireless infrastructure providers, wireless equipment distributors, value added resellers, and original equipment manufacturers through distributors and direct sales force. The company was founded in 1994 and is headquartered in Bloomingdale, Illinois.
- [By Stephen Simpson, CFA]
I’m perfectly happy recycling past investment ideas, and PCTEL (PCTI) treated me quite well indeed when I owned the stock about a decade ago. Since that time, though, the company has gone through a significant transformation and is really only the same in name only. Different isn’t always better, but I do believe that PCTEL now operates a collection of businesses with interesting growth and margin potential. PCTEL does not appear to be tremendously undervalued today on a cash flow basis, but with almost $3 per share in cash on the balance sheet further acquisitions could improve its growth prospects further.
- [By Roberto Pedone]
PCTEL (PCTI) designs and develops software-based radios for wireless network optimization and develops and distributes innovative antenna solutions. This stock closed up 1.1% to $9.83 in Tuesday’s trading session.
Tuesday’s Range: $9.70-$9.85
52-Week Range: $5.65-$10.00
Thursday’s Volume: 77,000
Three-Month Average Volume: 80,200
From a technical perspective, PCTI bounced modestly higher here right above some near-term support at $9.50 with decent upside volume. This stock has been trending sideways in a consolidation pattern for the last month, with shares moving between $9.08 on the downside and $10 on the upside. Shares of PCTI are now quickly moving within range of triggering a major breakout trade. That trade will hit if PCTI manages to take out its 52-week high at $10 with high volume.
Traders should now look for long-biased trades in PCTI as long as it’s trending above near-term support at $9.50 or above $9.08 and then once it sustains a move or close above $10 with volume that hits near or above 80,200 shares. If that breakout triggers soon, then PCTI will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $12 to $13.
Top Tech Companies To Invest In Right Now: Gilead Sciences Inc.(GILD)
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fos t er City, California.
- [By Ben Levisohn]
Biotech stocks have been slammed recently and Morgan Stanley believes it’s time to start differentiating between the fundamentals of companies like Amgen (AMGN), Biogen Idec (BIIB), Celgene (CELG) and Gilead Sciences (GILD).
- [By Ben Levisohn]
No, says Credit Suisse analyst Ravi Mehrotra and team, when contemplating the recent drops in Gilead Sciences (GILD), Biogen Idec (BIIB), Celgene (CELG) and their ilk. They explain why:
- [By Bernadette Tansey]
Geleziunas, director of clinical virology at Foster City, CA-based Gilead Sciences (NASDAQ: GILD ) is trying to thwart a second, more insidious way the HIV virus invades cells. Early in the course of infection, the virus inserts itself into the genome of immune system cells, but without either copying itself or killing the cell. The cell and the virus then wait together in a kind of slumber. But they can later awaken to unleash a new generation of infectious virus particles.
- [By Susan J. Aluise]
The Takeaway: NVAX shares have gained 150% in the past year and the company is well positioned with a promising proprietary technology — demand for these vaccines will be global. As a small-cap biotech stock with a fairly focused pipeline, risk and volatility are part of the equation — and profits will not come quickly. This stock is best suited for investors who are looking for aggressive growth, have a longer investment horizon and have a higher-than-average tolerance for risk.
Biotech Stocks: Gilead Sciences (GILD)
Type: Large-cap stock
Market Cap: $113 billion
Top Tech Companies To Invest In Right Now: Motorola Solutions Inc (MSI)
Motorola Solutions, Inc. (Motorola Solutions), incorporated March 9, 1973, provides communication infrastructure, devices, software and services. The Company provides these products and services for enterprise and government customers worldwide. The Company operates in two segments: Government and Enterprise. The Government segment includes sales of public safety communications systems, commercial two-way radio systems and devices, software and services. The Enterprise segment includes sales of rugged and enterprise-grade mobile computers and tablets, laser/imaging/RFID-based data capture products, wireless local area network (WLAN) and integrated digital enhanced network (iDEN) infrastructure, software and services. In January 2014, the Company announced that it has acquired Twisted Pair Solutions, a provider of push-to-talk over broadband applications for secure, real-time communication anywhere, on any device.
The Government segment designs, manufactures, sells, and provides services around voice and data communications systems, devices, security products and applications. These products and services are sold to a range of customers, including government, public safety and first responder agencies, as well as commercial customers who operate private communications networks and manage a mobile workforce.
The Company offer a portfolio of network infrastructure, devices, applications and services, based on Association for Public Safety Communications Officials 25 (APCO), terrestrial trunked radio (TETRA), and digital mobile radio (DMR) standards, as well as broadband technologies (Long-Term Evolution (LTE) and WiFi). Its products and services are sold stand alone, as well as part of an integrated system. In addition, Motorola Solutions offer critical applications in the public safety command center, including voice, computer aided dispatch and multimedia/video. The Company’s service offering includes mobility consulting, system design and installatio! n, network and device management and product support.
The Company competes with Cassidian/EADS, Harris, Hytera, Kenwood, Sepura and Tait.
The Enterprise segment designs, manufactures, sells and provides services around WLAN infrastructure, rugged and enterprise-grade advanced data capture and mobile computing devices, security products and applications. These are sold to a range of enterprise customers, including those in retail and hospitality, transportation and logistics, manufacturing, energy and utilities, education and healthcare. Motorola Solutions offers a portfolio of devices, infrastructure, applications and services, which include rugged and enterprise-grade mobile computers and tablets, laser/imager/RFID based data capture devices and kiosks, WLAN switches/controllers and access points, network and device management software, network and device security software, voice-based devices and software, and systems bas ed iDEN technology.
The Company competes with Apple, Aruba, Bluebird, Cisco, Datalogic, Honeywell, Hewlett Packard, Intermec, Psion, Panasonic and Samsung.
- [By MONEYMORNING.COM]
In this market, with a strong financial turnaround in place – and a stable of high-quality customers that include Motorola Solutions Inc. (NYSE: MSI), Hitachi Ltd. (ADR) (OTC: HTHIY), and General Electric Co. (NYSE: GE) – Adept could easily turn into a takeover candidate, Michael said.
- [By Laura Brodbeck]
Stocks moving in the Premarket included:
Walgreen Co. (NYSE: WAG) gained 0.60 percent in premarket trade after losing 2.86 percent over the past week. Walt Disney Co. (NYSE: DIS) was up 0.56 percent in premarket trade after falling 1.12 percent on Tuesday. Freeport-McMoRan Copper & Gold Inc (NYSE: FCX) lost 1.01 percent in premarket trade after falling 9.44 percent over the past five days. Motorola Solutions Inc (NYSE: MSI) was down 0.85 percent in premarket trade after losing 0.53 percent on Tuesday.
Top Tech Companies To Invest In Right Now: Clearwire Corporation(CLWR)
Clearwire Corporation, through its subsidiaries, provides fourth generation wireless broadband services in the United States. The company builds and operates mobile broadband networks that offer high-speed mobile Internet and residential Internet access services. It serves retail customers through its CLEAR brand. The company markets its products and services directly to consumers, as well as through cellular retailers, consumer electronics stores, satellite television dealers, and computer sales and repair stores; and through company-operated retail outlets. As of December 31, 2011, it had approximately 1.3 million retail and 9.1 million wholesale subscribers. The company is headquartered in Bellevue, Washington. Clearwire Corporation is a subsidiary of Sprint HoldCo LLC.
- [By Michael Lewis]
DISH Network (NASDAQ: DISH ) has lots and lots of cash — more than $7 billion following this week’s debt issuance. As opposed to other cash hoarders, there’s no secret as to what the company wants to spend it on. DISH is knee-deep in the race for spectrum and wireless buildout to launch its much-anticipated 4G network. The question is, where will the company make its purchase? As Sprint (NYSE: S ) and Clearwire (NASDAQ: CLWR ) continue to cozy up, the satellite-television provider will likely have to look elsewhere for its spectrum bundle. Where will the billions go?
- [By Michael Lewis]
While the majority of news regarding the M&A world revolves around the Dell takeover, one long, drawn-out battle continues for wireless company Clearwire (NASDAQ: CLWR ) . Telecom giant Sprint Nextel (NYSE: S ) is the majority shareholder of the beleaguered, spectrum-rich company, and the leading prospect for the acquisition. But with competing (and more appealing) offers from other suitors and a minority shareholder suit on the rise, it looks like this battle isn’t anywhere near over. What should investors expect for the future of Clearwire?
- [By Evan Niu, CFA]
There aren’t a whole lot of things that Clearwire (NASDAQ: CLWR ) has that Verizon (NYSE: VZ ) wants, but spectrum is certainly one of them. The Wall Street Journal reports that Big Red has offered Clearwire up to $1.5 billion to take some chunks of spectrum off its hands. Clearwire has valuable spectrum holdings in numerous key domestic markets, which Verizon could use to boost network capacity.
- [By Rich Duprey]
Yet telecom presented an interesting avenue of attack, too, as Verizon (NYSE: VZ ) had the second “less bad” performance of Dow components, pulling back by less than half of a percent. That was no doubt largely in response to a two-fold development: its willingness to pay $1.5 billion for Clearwire’s (NASDAQ: CLWR ) spectrum and DISH Network’s (NASDAQ: DISH ) offer to buy Sprint Nextel (NYSE: S ) for $25.5 billion.
Top Tech Companies To Invest In Right Now: Incyte Corporation(INCY)
Incyte Corporation focuses on the discovery and development of proprietary small molecule drugs for hematologic and oncology indications, and inflammatory and autoimmune diseases. Its product pipe line includes INCB18424, which is in Phase III clinical trial for myelofibrosis; Phase III trial for polycythemia vera; Phase III trial for essential thrombocythemia; Phase I/II trial to treat solid tumors/other hematologic malignancies; and Phase IIb trail for the treatment of psoriasis. The company?s portfolio also includes INCB28050, a Phase IIb clinical trial product for rheumatoid arthritis; INCB28060, a Phase I/II product for solid tumors; INCB7839, a Phase II product for breast cancer; and INCB24360, a Phase I/II product for solid tumors. It has a collaborative research and license agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; and Pfizer Inc. The company was founded in 1991 and is headquartered in Wilmington, Delaware.
- [By John McCamant]
Incyte Pharmaceuticals (INCY) recently held their quarterly conference call. Importantly, sales for Jakafi—an advanced compound used for the treatment of patients with intermediate or high-risk myelofibrosis (MF)—met or exceeded Wall Street’s expectations.
- [By Ben Levisohn]
Sure Intercept Pharmaceuticals (ICPT) might feel like the only biotech stock that matters today, but there are others. For instance, Incyte (INCY) and BioMarin (BMRN) are on the move after Barclays changed its ratings on the pair.
- [By Ben Levisohn]
Somaiya and team named Gilead and Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
Top Tech Companies To Invest In Right Now: Imprimis Pharmaceuticals Inc (IMMY)
Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company’s Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company’s lead pain product, utilizes the Transdel platform technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its anti-inflammatory and analgesic effects. Ketotransdel consists of a transdermal formulation of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its Transdel drug delivery system and is being developed for the treatment of acute pain. In July 2013, it acquired intellectual property for IPI-120 from Buderer Drug Company.
Ketotransdel penetrates the skin barrier to reach the targeted underlying tissues where it ex erts its localized anti-inflammatory and analgesic effect. Transdel is the Company’s transdermal cream drug delivery platform. It consists of a cream that enables transdermal penetration of drugs avoiding first pass metabolism by the liver and minimizing systemic exposure. The Transdel drug delivery system facilitates the effective dissolution and delivery of a drug across the skin barrier to reach targeted underlying tissues.
- [By John Udovich]
So far this year, Rexahn Pharmaceuticals, Inc (NYSEMKT: RNN), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and Arrowhead Research Corp (NASDAQ: ARWR) are up 186.3%, 157.2% and 142.5%, respectively, since the start of the year – making them the best performing small cap biotech stocks for 2014. But given their lackluster performance over the past few years, what is the secret behind their phenomenal 2014 rise and will they keep rising? For starters, none of these small caps have really produced anything in the way of blockbuster news:
- [By John Udovich]
The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many…) planned biotech IPOs that have recently been announced publicly:
Top Tech Companies To Invest In Right Now: EMC Corporation(EMC)
EMC Corporation develops, delivers, and supports the information and virtual infrastructure technologies and solutions. The company offers enterprise storage systems and software, which are deployed in storage area networks (SAN), networked attached storage (NAS), unified storage combining NAS and SAN, object storage, and/or direct attached storage environments, as well as provides backup and recovery, and disaster recovery and archiving solutions. It also offers information security solutions in various areas, such as enterprise governance, risk and compliance, data loss prevention, security information management, continuous network monitoring, fraud protection, identity assurance and access control, and encryption and key management. In addition, the company provides information intelligence software, solutions, and services, including EMC Captiva for intelligent enterprise capture; EMC Document Sciences for customer communications management; EMC Kazeon for e-discovery ; EMC Documentum xCP for building business solutions and an action engine for big data; and the EMC Documentum platform for managing and delivering enterprise information. Further, it offers virtual and cloud infrastructure products, such as virtualization and virtualization-based cloud infrastructure solutions that address a range of IT problems, as well as facilitate access to cloud computing capacity, business continuity, software lifecycle management, and corporate end-user computing device management In addition, the company provides consulting, technology deployment, managed, customer support, and training and certification services. EMC Corporation markets its products through direct sales and through multiple distribution channels in North America, Latin America, Europe, the Middle East, South Africa, and the Asia Pacific region. The company was founded in 1979 and is headquartered in Hopkinton, Massachusetts.
- [By Traders Reserve]
EMC (EMC) reported a strong set of fourth-quarter results recently, led by a 10% growth in the Information Storage division and sustained growth from EMC-owned VMware (VMW).
- [By John Kell]
EMC Corp.(EMC) said its fourth-quarter earnings grew 17% as the data-storage provider benefited from strong growth in its emerging storage business. However, its stock declined 2.3% premarket to $24.81 after the company forecast 2014 results below market expectations.
- [By GURUFOCUS]
EMC (EMC)’s stock was flat over the course of 2013. In fact, the stock has been flat over the past three years – sigificantly underperforming the near 50% gain in the S&P 500 Index. The stock has been buffetted over fears that the Company’s current decelerated growth is in secular decline due to a number of competitive threats. The first threat is that flash storage and software-defined storage will cannibalize traditional hard disk drives. Two, the public cloud is only a threat (and not an opportunity) that disintermediates information technology (IT) spend from both EMC and VMware (EMC maintains an over 80% ownership stake in VMW). Third, VMware’s entrenched vSphere gets displaced by Open-Source and Microsoft’s Hyper-V. Fourth, recent premium-priced acquisitions of Data Domain and Isilon are evidence of lack of internal product development.
- [By Dan Caplinger]
Fusion-io (NYSE: FIO ) will release its quarterly report on Wednesday, and investors are nervous about the expected plunge in revenue that they expect to result in the data-storage specialist’s year-ago profit turning into a loss. Yet even in the face of much larger competitors EMC (NYSE: EMC ) and Western Digital (NASDAQ: WDC ) , many still hold out hope that Fusion-io earnings will eventually recover and help the share price gain back some of its long-term losses.
Top Tech Companies To Invest In Right Now: Peregrine Semiconductor Corp (PSMI)
Peregrine Semiconductor Corporation (Peregrine), incorporated in February 1990, is engaged in the design, manufacturing and marketing radio frequency integrated circuits (RFICs) for the aerospace and defense, broadband, industrial, mobile wireless device, test and measurement equipment, and wireless infrastructure markets. The Company is provider of RFICs. Its products include RF switches-antenna, RFswitches-broadband and general purpose, digital attenuators, synthesizers, mixers/upconverters, prescalers, variable gain amplifiers, digitally tunable capacitors, DC-DC converters and power amplifiers. Its UltraCMOS technology enables the design, manufacture, and integration of multiple radio frequency (RF), mixed signal, and digital functions on a single chip. Its solutions target a range of applications in the aerospace and defense, broadband, industrial, mobile wireless device, test and measurement equipment, and wireless infrastructure markets.
As of December 25, 2010, The Company offers a portfolio of more than 120 RFICs, including switches, digital attenuators, mixers/upconverters, and prescalers, and it is developing power amplifiers (Pas), digitally tunable capacitors (DTCs), and DC-DC converters. During the fiscal year ended December 25, 2010, its products were sold to more than 1,400 module manufacturers, original equipment manufacturers (OEMs), contract manufacturers, and other customers, including such companies as Amalfi Semiconductor, Inc., The Boeing Company, EPCOS AG, Ericsson AB, Hitachi Media Electronics Company, Ltd., Hitachi Metals, Ltd., Humax Co., Ltd., Itron, Inc., LG Innotek Co., Ltd., Mini-Circuits, Inc., Motorola, Inc., Murata Manufacturing Company, Ltd., Planet Technology Corp., Rockwell Collins, Inc., Rohde & Schwarz, Inc., SIPAT Co., Ltd., Skyworks Solutions, Inc., Sony Corporation, Source Photonics, Inc., and Thales Alenia Space.
RF Switches are utilized in the RF section of mobile devices to route RF signals between! the antenna and the handset core, through one or more signal paths. For mobile handsets, its switch products offer up to 10 RF signal paths with integrated digital bus support and onboard voltage regulation.
RFswitches-broadband and general purpose
The Company’s broadband and general purpose RF switches deliver combination of broadband linearity, settling time, and isolation while routing RF signals to their respective transmit or receive paths. Its attributes are being used by the OEMs of LED and plasma digital televisions (DTVs), set top box, cable infrastructure, test and measurement devices
The Company provides digital step attenuators that are used to control the amplitude of an RF or analog signal. The products include digital control circuitry integrated with an RF attenuator core and are used in third generation (3G) and fourth generation (4G) cellular base stations, repeaters, and point-to-p oint nodes.
The Company’s frequency synthesizers provide an electronic system for generating any of a range of frequencies from a single fixed timebase or oscillator. Its synthesizers provide low-power, ultra-low phase noise, programmable frequency synthesis for defense, broadband, industrial, and wireless infrastructure markets.
The Company’s mixers/upconverters are used to translate encoded voice/data signals from one frequency to another to enable radio transmission. Its mixers / upconverters are incorporated into mixer modules and provide industry linearity, which is a metric to maximizing wireless data transmission rates. These attributes are critical in 3G and 4G cellular base station designs.
The Company’s prescalers operate in the C, X, and Ku bands to divide the frequency of a wireless signal in order to extend the operating range of a sy nthesizer beyond its base capability. Its prescalers complem! ent its f! requency synthesizer line, providing its customers with design.
Variable Gain Amplifiers
The Company’s Variable Gain Amplifiers (VGAs) are used in both the receiving and transmitting path of a radio system to maintain a signal’s strength at a level necessary for other circuits to operate optimally. Its DVGA is the monolithic integrated circuit (IC) to integrate three functional blocks, including digital attenuators, RF/IF amplifiers and a common serial interface onto a single IC.
The Company’s frequency-configurable DC-DC converters efficiently perform voltage conversion using a high frequency switching technique that minimizes system noise. Its DC-DC converters are designed to enable a distributed power management architecture designed for satellite applications, replacing inefficient drop out regulators and central converters.
The Company’s PAs amplify RF sign als in order to generate the necessary power required to establish a radio link between a base station and a mobile device. With its UltraCMOS technology the Company has the ability to integrate its PAs on a single chip with other RF, mixed signal, and digital components.
The Company competes with Hittite, M/A-COM, NEC, Renesas, RFMD, Skyworks, Sony, Toshiba and TriQuint Semiconductor.
- [By Lee Jackson]
Peregrine Semiconductor Corp. (NASDAQ: PSMI) is a lesser known name that is a top stock to buy at Deutsche Bank. The company recently released a new radio frequency (RF) switch specifically designed for broadband cable systems. With HD content exploding, this could be a huge home run for the company. Deutsche Bank has a $14 price target for the stock, the same as the consensus target.